Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia

1. Gómez García, L.M.
2. Escudero, A.
3. Mestre, C.
4. Fuster Soler, J.L.
5. Martínez, A.P.
6. Vagace Valero, J.M.
7. Vela, M.
8. Ruz, B.
9. Navarro, A.
10. Fernández, L.
11. Fernández, A.
12. Leivas, A.
13. Martínez-López, J.
14. Ferreras, C.
15. De Paz, R.
16. Blanquer, M.
17. Galán, V.
18. González, B.
19. Corral, D.
20. Sisinni, L.
21. Mirones, I.
22. Balas, A.
23. Vicario, J.L.
24. Valle, P.
25. Borobia, A.M.
26. Pérez-Martínez, A.
27. Mostrar todos los/as autores/as +